Pharma Pioneer: Murali Divi | Murali Divi founded Divi’s Laboratories 34 years ago as a drug research firm. The company is now among the world’s top suppliers of active pharmaceutical ingredients. Divi also manufactures custom products for big pharma and produces nutraceuticals. Nearly 90% of the company’s $953 million revenue comes from exports. According to Forbes India, Murali Divi’s net worth is $10 billion, making him Hyderabad’s wealthiest individual. (Image: Forbes India)
Infrastructure Builder: P.P. Reddy | P.P. Reddy founded Megha Engineering Enterprises in 1989 to build small municipal pipes. He later expanded into infrastructure projects, including dams, roads, power plants, and natural gas networks. The company was renamed Megha Engineering and Infrastructure in 2006. It is now run by his nephew, P.V. Krishna Reddy. Together, their combined net worth is $2.1 billion, reflecting decades of growth in construction and industry. (Image: Forbes India)
Generics Legacy: Reddy Family | The Reddy family owns Dr. Reddy’s Laboratories, a generics and pharma ingredient company founded in 1984 by K. Anji Reddy. The firm is now led by Satish Reddy and G.V. Prasad as chairman and co-chairman. Nearly half of its revenue comes from North America, with India contributing a fifth. The company has expanded into nutraceuticals, cell and gene therapy, and digital healthcare. Their net worth is $3.67 billion. (Image: Forbes India)
Anti-Retroviral Leader: B. Partha Saradhi | B. Partha Saradhi Reddy is chairman of Hetero Group, which he founded in 1993. The company produces more than 200 products, including anti-retroviral drugs, cancer treatments, and diabetes therapies. It manufactures both branded and non-branded generics. Hetero’s medicines serve global markets. Partha Saradhi Reddy is also a member of the Rajya Sabha, India’s upper house of Parliament. His net worth stands at $3.8 billion. (Image: Forbes India)
Vaccine Innovator: Mahima Datla | Mahima Datla manages Biological E, a Hyderabad-based vaccine producer in which she holds a controlling stake. The company developed Corbevax, a COVID-19 vaccine in partnership with Houston’s Baylor College of Medicine. Biological E has 10 WHO-prequalified vaccines, including those for polio, tetanus, and measles. It exports to over 130 countries. Founded in 1953 by her grandfathers, the company has grown under her leadership, giving her a net worth of $3.3 billion. (Image: Forbes India)
Pharma Co-Founder: P.V. Ramprasad | P.V. Ramprasad Reddy, co-founder of Aurobindo Pharma, has a net worth of $3.8 billion. The company was founded in 1986 and makes drugs for diseases, including diabetes and cardiac conditions. It earns nearly three-fourths of its revenue from the U.S. and Europe. Aurobindo began with a single plant in Pondicherry and in 2023, received approval to launch the cancer drug Revlimid in India. (Image: Forbes India)
